Santhera Pharmaceuticals Holdings Ltd
Santhera Pharmaceuticals Holdings.../ CH1276028821 /
SPHDD
|
- -
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
-USD
|
-
|
2,980
Turnover: - |
-Bid Size: - |
-Ask Size: - |
134.16 mill.USD |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
4.34 CHF |
- |
| EPS Diluted: |
- CHF |
- |
| Revenues per Share: |
8.19 CHF |
725.59% |
| Book Value per Share: |
4.79 CHF |
- |
| Cash Flow per Share: |
3.77 CHF |
- |
| Dividend per Share: |
- CHF |
- |
| Total |
in mill. |
|
| Revenues: |
103.38 CHF |
1,283.33% |
| Net Income: |
54.78 CHF |
- |
| Operating Cash Flow: |
47.62 CHF |
- |
| Cash and Cash Equivalents: |
30.37 CHF |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
2.19 |
2.26 |
| P/S Ratio: |
1.16 |
1.20 |
| P/BV ratio: |
1.98 |
2.05 |
| P/CF Ratio: |
2.52 |
2.60 |
| PEG: |
- |
- |
| Earnings Yield: |
45.68% |
44.24% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
134.16 mill. USD |
147.18 mill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
12.62 mill. |
|
Profitability
| Gross Profit Margin: |
96.87% |
| EBIT Margin: |
66.56% |
| Net Profit Margin: |
52.99% |
| Return on Equity: |
90.60% |
| Return on Assets: |
49.97% |
Financial Strength
| Liquidity I / Cash Ratio: |
69.35% |
| Liquidity II / Quick Ratio: |
74.27% |
| Liquidity III / Current Ratio: |
79.14% |
| Debt / Equity Ratio: |
81.31% |
| Dynam. Debt / Equity Ratio: |
103.24% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- CHF |
| Revenues / Employee: |
- CHF |
| Net Income / Employee: |
- CHF |
| Total Assets / Employee: |
- CHF |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
IFRS |
